A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 3156632)

Published in J Gerontol A Biol Sci Med Sci on June 30, 2011

Authors

Loic Desquilbet1, Lisa P Jacobson, Linda P Fried, John P Phair, Beth D Jamieson, Marcy Holloway, Joseph B Margolick

Author Affiliations

1: Ecole nationale veterinaire d'Alfort, 7 Avenue du General de Gaulle, Maisons-Alfort Cedex, France. loic.desquilbet@gmail.com

Associated clinical trials:

Exercise Training to Improve Brain Health in Older HIV+ Individuals (Ex/HIV) | NCT02663934

Articles citing this

Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc (2013) 2.06

HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis (2015) 1.70

Management of human immunodeficiency virus infection in advanced age. JAMA (2013) 1.51

Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One (2013) 1.46

Health and functional status among older people with HIV/AIDS in Uganda. BMC Public Health (2011) 1.27

Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci (2013) 1.19

Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials (2012) 1.19

Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr (2013) 0.99

Geriatric Syndromes in Older HIV-Infected Adults. J Acquir Immune Defic Syndr (2015) 0.99

Pain is independently associated with impaired physical function in HIV-infected patients. Pain Med (2013) 0.97

Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep (2014) 0.91

An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr (2014) 0.88

Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neurovirol (2015) 0.82

Efavirenz is associated with higher bone mass in South African children with HIV. AIDS (2016) 0.82

Relationship of physical function and quality of life among persons aging with HIV infection. AIDS (2014) 0.81

Understanding frailty, aging, and inflammation in HIV infection. Curr HIV/AIDS Rep (2015) 0.80

Assessment of geriatric syndromes and physical function in people living with HIV. Virulence (2016) 0.78

Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco. J Acquir Immune Defic Syndr (2016) 0.77

The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men. Br J Cancer (2013) 0.77

Pilot study of younger and older HIV-infected adults using traditional and novel functional assessments. HIV Clin Trials (2013) 0.77

Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women - The Women's Interagency HIV Study. J Frailty Aging (2016) 0.76

Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy. J Infect Dis (2017) 0.76

Falls among middle-aged women in the Women's Interagency HIV Study. Antivir Ther (2016) 0.76

Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2017) 0.75

Frailty and Components of the Frailty Phenotype are Associated with Modifiable Risk Factors and Antiretroviral Therapy. J Infect Dis (2017) 0.75

Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men. Cancer Med (2014) 0.75

Ocular parameters of biological ageing in HIV-infected individuals in South Africa: relationship with chronological age and systemic biomarkers of ageing. Mech Ageing Dev (2013) 0.75

Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs. Curr HIV/AIDS Rep (2016) 0.75

Frailty Screening and Interventions: Considerations for Clinical Practice. Clin Geriatr Med (2018) 0.75

Geriatric-HIV medicine: A science in its infancy. Virulence (2017) 0.75

Faces of Frailty in Aging with HIV Infection. Curr HIV/AIDS Rep (2017) 0.75

Articles cited by this

Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care (1994) 19.87

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40

Flexible regression models with cubic splines. Stat Med (1989) 14.45

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci (2004) 12.46

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA (2008) 11.72

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology (2006) 10.18

Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci (2006) 8.00

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48

Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81

Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73

Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg (2010) 5.72

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS (2007) 4.31

Dose-response analyses using restricted cubic spline functions in public health research. Stat Med (2010) 3.58

Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc (2007) 3.15

Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci (2009) 3.14

Unstable disability and the fluctuations of frailty. Age Ageing (1997) 3.03

HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75

Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med (2005) 2.74

Frailty: an emerging geriatric syndrome. Am J Med (2007) 2.63

Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48

A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci (2002) 2.38

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med (2002) 2.36

From bedside to bench: research agenda for frailty. Sci Aging Knowledge Environ (2005) 2.19

Physiological complexity, aging, and the path to frailty. Sci Aging Knowledge Environ (2004) 2.14

Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry (1993) 2.07

Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther (2008) 1.83

Frailty, morbidity and survival. Arch Gerontol Geriatr (2005) 1.75

Aging, disability and frailty. Ann Nutr Metab (2008) 1.74

Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr (2009) 1.69

The frailty syndrome: a critical issue in geriatric oncology. Crit Rev Oncol Hematol (2003) 1.58

Embracing chaos and complexity: a quantum change for public health. Am J Public Health (2008) 1.43

Frailty and the degradation of complex balance dynamics during a dual-task protocol. J Gerontol A Biol Sci Med Sci (2009) 1.28

Biomarkers of frailty in older persons. J Endocrinol Invest (2002) 1.25

Frailty thy name is ... Phrailty? J Gerontol A Biol Sci Med Sci (2007) 1.22

Frailty of older age: the role of the endocrine--immune interaction. Curr Pharm Des (2006) 1.03

Conference on the physiologic basis of frailty. April 28, 1992, Baltimore, Maryland, U.S.A. Introduction. Aging (Milano) (1992) 1.00

Understanding frailty. J Gerontol A Biol Sci Med Sci (2009) 0.85

Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991. Am J Epidemiol (1993) 0.84

Articles by these authors

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA (2005) 20.53

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med (2003) 9.75

Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci (2006) 8.00

Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc (2006) 6.81

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity (2012) 6.29

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02

Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00

Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc (2004) 5.80

Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg (2010) 5.72

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med (2002) 4.97

Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences. J Virol (2003) 4.56

Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) (2012) 4.36

Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med (2004) 4.06

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05

LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell (2008) 4.02

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet (2002) 3.88

The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2007) 3.76

The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies. J Am Geriatr Soc (2005) 3.73

Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72

Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68

Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66

Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS (2008) 3.66

Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc (2004) 3.52

Thyroid status, cardiovascular risk, and mortality in older adults. JAMA (2006) 3.50

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol (2007) 3.46

Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. J Infect Dis (2007) 3.39

Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc (2003) 3.30

Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc (2005) 3.29

Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med (2014) 3.24

Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc (2002) 3.21

Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol (2004) 3.17

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10

Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr (2009) 2.88

Falls and fear of falling: which comes first? A longitudinal prediction model suggests strategies for primary and secondary prevention. J Am Geriatr Soc (2002) 2.85

The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis (2004) 2.83

Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci (2012) 2.82

Reliability and sensitivity to change assessed for a summary measure of lower body function: results from the Women's Health and Aging Study. J Clin Epidemiol (2002) 2.79

Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J Virol (2003) 2.78

HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci (2007) 2.75

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest (2009) 2.75

Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med (2005) 2.74

Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med (2007) 2.71

Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr (2002) 2.70

Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis (2007) 2.67

Inflammation and frailty in older women. J Am Geriatr Soc (2007) 2.66

Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol (2013) 2.64

Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology (2013) 2.61

Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2005) 2.59

Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA (2007) 2.59

Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS (2002) 2.57

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS (2005) 2.54

Association between screening for osteoporosis and the incidence of hip fracture. Ann Intern Med (2005) 2.52

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50

Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol (2008) 2.48

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS (2005) 2.48

HIV incidence determination in the United States: a multiassay approach. J Infect Dis (2012) 2.47

Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev (2005) 2.45

Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2008) 2.44

Treating our societal scotoma: the case for investing in geriatrics, our nation's future, and our patients. Ann Intern Med (2012) 2.44

Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2009) 2.32

Optimization of methods to assess human mucosal T-cell responses to HIV infection. J Immunol Methods (2003) 2.32

Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2005) 2.32

Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol (2007) 2.30

Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol (2005) 2.20

Anatomical loci of HIV-associated immune activation and association with viraemia. Lancet (2003) 2.19

U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18

Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. J Virol (2011) 2.18

What constitutes normal hemoglobin concentration in community-dwelling disabled older women? J Am Geriatr Soc (2004) 2.18

Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS (2014) 2.18

Dual HIV-1 infection associated with rapid disease progression. Lancet (2004) 2.17

Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011. Clin Infect Dis (2013) 2.15

Change in physical performance over time in older women: the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci (2002) 2.13

The association of race with frailty: the cardiovascular health study. Ann Epidemiol (2006) 2.11

Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab (2003) 2.09

Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci (2005) 2.08

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05

Experience Corps: design of an intergenerational program to boost social capital and promote the health of an aging society. J Urban Health (2004) 2.04

Oxidative protein damage is associated with poor grip strength among older women living in the community. J Appl Physiol (1985) (2007) 2.04

Microbial translocation, the innate cytokine response, and HIV-1 disease progression in Africa. Proc Natl Acad Sci U S A (2009) 2.03

Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study. Diabetes Care (2002) 2.03

Just get out the door! Importance of walking outside the home for maintaining mobility: findings from the women's health and aging study. J Am Geriatr Soc (2005) 2.03

"Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med (2003) 2.02

Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study. J Infect Dis (2008) 2.01